FindTrial
Sign In

Clinical evaluation of the effect of Kimshuka Kshara Bhavita Pippali in patients with non alcoholic fatty liver disease

Clinical evaluation of the hepatocorrective effect of Kimshuka Kshara Bhavita Pippali in patients with non alcoholic fatty liver disease - KKBP NAFLD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111233
Enrollment
60
Registered
2026-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Glocal College of Ayurvedic Medical Science and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with non alcoholic fatty liver disease grade one or grade two by ultrasonography willing to provide informed consent

Exclusion criteria

Exclusion criteria: Patients with alcoholic liver disease viral hepatitis severe systemic illness pregnancy lactation and patients using hepatotoxic or antioxidant drugs

Design outcomes

Primary

MeasureTime frame
Assessment of hepatocorrective effect using serum ALT AST ALP total bilirubin direct bilirubin and ultrasonographic grading of fatty liverTimepoint: Day zero Day thirty and Day sixty—

Secondary

MeasureTime frame
Assessment of improvement in abdominal heaviness fatigue appetite abdominal discomfort bloating safety and tolerabilityTimepoint: Day zero Day thirty and Day sixty—

Countries

India

Contacts

Public ContactDr Arathi V

Glocal University

drgovindan@rediffmail.com9447389578

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026